Gilead Sciences Inc

Visual Financials
Company Name: Gilead Sciences Inc
Ticker Symbol: GILD
CIK Number: 0000882095
WWW Address: http://www.gilead.com
CEO: Mr. Daniel O’Day
No. of Employees: 9,000
Common Issue Type: CS
Business Description:Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 64.91 Unchanged 0.0 64.5 65.01  64.80 63.57 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 82,536.6 1,271.6 0.00 4.20 2.52 16.0 3.5 79.61 - 60.10
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close63.73$
PE Ratio - LTM16.0
Market Capitalisation82,536.6mil
Latest Shares Outstanding1,271.6mil
Earnings pS (EPS)4.20$
Dividend pS (DPS)2.52¢
Dividend Yield3.5%
Dividend Payout Ratio1%
Revenue per Employee2,011,545$
Effective Tax Rate0.3%
Float1,274.1mil
Float as % of Shares Outstanding1.0%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.20%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin78.1%
EBITDA Margin46.6%
Pre-Tax Profit Margin0.0%
Assets Turnover33.0%
Return on Assets (ROA)8.1%
Return on Equity (ROE)26.1%
Return on Capital Invested (ROCI)12.1%
Current Ratio3.4
Leverage Ratio (Assets/Equity)3.0
Interest Cover8.2
Total Debt/Equity (Gearing Ratio)1.28
LT Debt/Total Capital53.0%
Working Capital pS19.84$
Cash pS0.00$
Book-Value pS17.26$
Tangible Book-Value pS1.20$
Cash Flow pS5.83$
Free Cash Flow pS5.10$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.87
Price/Tangible Book Ratio0.00
Price/Cash Flow11.5
Price/Free Cash Flow13.1
P/E as % of Industry Group109.0%
P/E as % of Sector Segment22.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of PaymentStock Payment
Dividend Rate2.52
Current Dividend Yield3.5
5-Y Average Dividend Yield0.0
Payout Ratio1.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---2.45,932,56623,706,064
4 Weeks67.5262.0065.57-2.85,982,616113,669,721
13 Weeks68.0761.3863.330.66,529,470411,356,644
26 Weeks70.5060.1068.15-6.57,014,976869,857,103
52 Weeks79.6160.1071.91-11.46,760,5501,690,137,607
YTD70.5061.38-0.56,827,270737,345,211
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
63.6764.3165.2866.2468.410.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.150.1-0.12
Income0.120.1-0.33
Dividend0.40.21
Capital Spending0.22NA-0.26
R&D22.15NA21.44
Normalized Inc.13.37NA2.73
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %10.910.915.7
Earnings %64.064.0-7.7
EPS %50.950.9-7.6
EPS $0.150.15-0.14
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio39.62
Current Ratio3.4
Quick Ratio (Acid Test)3.2
Liquidity Ratio (Cash)4.53
Receivables Turnover6.2
Average Collection Period58
Working Capital/Equity118.0
Working Capital pS19.78
Cash-Flow pS6.42
Free Cash-Flow pS5.72
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio1.42
Financial Leverage Ratio (Assets/Equity)1.3
Debt Ratio42.9
Total Debt/Equity (Gearing Ratio)1.28
LT Debt/Equity1.15
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities89.9
Interest Cover8.2
Interest/Capital Invested5.04
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.34
Current P/E Ratio - LTM16.00
Enterprise Value (EV)/EBITDA3.59
Enterprise Value (EV)/Free Cash Flow7.91
Dividend Yield3.5
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.87
Price/Cash Flow Ratio11.5
Price/Free Cash Flow Ratio - LTM13.1
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM30.6
P/E Ratio (26 weeks ago) - LTM23.1
P/E Ratio (52 weeks ago) - LTM15.1
5-Y High P/E Ratio27.2
5-Y Low P/E Ratio13.3
5-Y Average P/E Ratio16.9
Current P/E Ratio as % of 5-Y Average P/E-27
P/E as % of Industry Group109.0
P/E as % of Sector Segment22.0
Current 12 Month Normalized P/E Ratio - LTM29.1
PER SHARE FIGURES
LT Debt pS18.91
Current Liabilities pS8.16
Tangible Book Value pS - LTM1.20
Book Value pS - LTM17.26
Capital Invested pS38.31
Cash pS - LTM0.00
Cash Flow pS - LTM5.83
Free Cash Flow pS - LTM5.10
Earnings pS (EPS)4.20
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin33.79
Free Cash Flow Margin 5YEAR AVG47.75
Net Profit Margin0.2
Net Profit Margin - 5YEAR AVRG.0.4
Equity Productivity1.03
Return on Equity (ROE)0.3
Return on Equity (ROE) - 5YEAR AVRG.0.6
Capital Invested Productivity0.45
Return on Capital Invested (ROCI)0.3
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.3
Assets Productivity0.30
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.2
Gross Profit Margin78.1
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM46.6
EBIT Margin - LTM40.1
Pre-Tax Profit Margin0.5
Pre-Tax Profit Margin - 5YEAR AVRG.0.5
Effective Tax Rate2.4
Effective Tax Rate - 5YEAR AVRG.4.6
EFFICIENCY RATIOS
Cash Conversion Cycle
Revenue per Employee2,011,545
Net Income per Employee495,909
Average Collection Period
Receivables Turnover6.2
Day's Inventory Turnover Ratio
Inventory Turnover6.0
Inventory/Sales3.7
Accounts Payble/Sales3.57
Assets/Revenue3.33
Net Working Capital Turnover0.88
Fixed Assets Turnover0.79
Total Assets Turnover0.3
Revenue per $ Cash1.23
Revenue per $ Plant5.52
Revenue per $ Common Equity1.03
Revenue per $ Capital Invested0.45
Selling, General & Adm/tive (SG&A) as % of Revenue18.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue22.7
R&D Expense as % of Revenue - 5YEAR AVRG.22.7

  


Your Recent History
NASDAQ
GILD
Gilead Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.